Purchase Order 75N91024P00336

This firm fixed price purchase order, awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute, is for $37,785.60 in mRNA and microRNA microarray profiling services to support the prediction of radiation therapy outcomes. The prime contractor is Genus Biosystems Inc., located in Northbrook, Illinois, and no set-aside designation was applied to this procurement. The contract completion date is August 19, 2024, suggesting the National Cancer...

The U.S. government awarded a $3,294 firm fixed-price purchase order to Genus Biosystems Inc. for microarray services on July 23, 2009, with an ultimate completion date of August 28, 2009. The contract was executed without a set-aside designation, allowing the vendor to compete in the open market. The work was performed at Genus Biosystems' facility in Northbrook, Illinois. Genus Biosystems Inc., a for-profit laboratory services provider specializing in genomics and transcriptomics analysis, has...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...

<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Diagenode, LLC for scientific equipment. Under the firm fixed price contract, Diagenode will provide the specified equipment to support the National Cancer Institute's research efforts. The place of performance is Diagenode's facility in Denville, New Jersey. The contract period runs from September 22, 2023 through December 26, 2023. No subcontractors or set...

<p>This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian federal agency, to Abiosciences Inc. for $14,000.00 to provide lab testing services. The award has an ultimate completion date of October 25, 2024 and was made on June 26, 2024. No set-aside designation is mentioned. The contract does not appear to be associated with a larger vehicle.</p>